[The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
Kiyoshi Matsui, Hiroki Iwamoto, N Ohtsuki, Takeshi Kobayashi, Shigeta Miyake, Masami Yamada
Abstract
Kiyoshi Matsui, Hiroki Iwamoto, N Ohtsuki, Takeshi Kobayashi, Shigeta Miyake, Masami Yamada
Abstract
Blood ammonia and serum free carnitine were measured in 49 severely handicapped epileptic patients treated with or without valproate. DL- or L-carnitine were administered to patients treated with valproate, and the effects of carnitine supplementation were evaluated. Furthermore we analyzed the relationship between serum free carnitine and nutrition. In patients treated with valproate, blood ammonia statistically increased, and serum free carnitine concentration statistically decreased. Free carnitine was low in tube-fed patients, as compared with that in oral-fed patients. Carnitine therapy was successful in improvement of hyperammonemia and hypocarnitinemia. It is concluded that hypocarnitinemia was caused not only by valproate therapy, but also by tube-feeding. Carnitine supplementation therapy is important to both hyperammonemia and hypocarnitinemia. But the long term effect of carnitine therapy remains to be studied further.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Blood ammonia and serum free carnitine were measured in 49 severely handicapped epileptic patients treated with or without valproate. DL- or L-carnitine were administered to patients treated with valproate, and the effects of carnitine supplementation were evaluated. Furthermore we analyzed the relationship between serum free carnitine and nutrition. In patients treated with valproate, blood ammonia statistically increased, and serum free carnitine concentration statistically decreased. Free carnitine was low in tube-fed patients, as compared with that in oral-fed patients. Carnitine therapy was successful in improvement of hyperammonemia and hypocarnitinemia. It is concluded that hypocarnitinemia was caused not only by valproate therapy, but also by tube-feeding. Carnitine supplementation therapy is important to both hyperammonemia and hypocarnitinemia. But the long term effect of carnitine therapy remains to be studied further.
Key concepts: Hyperammonemia, Carnitine, Medicine, Internal medicine, Anticonvulsant, Gastroenterology, Endocrinology, Epilepsy